Sickle Cell Genotype Testing Guide for Africa

Source review date: July 13, 2026. This guide was checked against the Federal Ministry of Health Nigeria's 2025 second-edition national sickle cell guideline, Africa CDC's continental-plan announcement dated May 13, 2026, and the WHO Regional Office for Africa's June 23 to 25, 2026 PEN-Plus conference programme. Testing pathways and services differ by country and facility, so confirm local practice with a qualified laboratory, clinician or genetic counsellor.

Why genotype testing needs more than a two-letter label

People commonly describe results as AA, AS, AC, SS or SC. These short labels are useful, but they can hide important questions. Was the test a first-line screen or a confirmatory method? Could another haemoglobin variant be present? Was the person recently transfused? Was the sample from a newborn? Does the printed result match the person's name and collection date? A responsible workflow begins with the report, method and clinical context, not only the two letters remembered from a past conversation.

Nigeria's national guideline lists several methods used in sickle cell diagnosis, including point-of-care tests, sickling tests, solubility tests, haemoglobin electrophoresis, high-performance liquid chromatography and isoelectric focusing. These methods do different jobs and have different limitations. The guideline describes point-of-care testing as a first-line screening approach in Nigeria. It also states that a solubility result suggesting sickle haemoglobin requires an unrelated second-line method for confirmation.

This distinction matters because a screening test answers a narrower question than a complete haemoglobin analysis. A positive screen can signal that haemoglobin S may be present, but it may not safely distinguish every trait or disease pattern. A laboratory professional or clinician should interpret the method, controls, limitations and result together.

What the common labels usually describe

Label	Common description	What to remember
HbAA	Two haemoglobin A alleles	The report still needs correct identity and a reliable method.
HbAS	Sickle cell trait	Trait is not the same as HbSS disease. The S allele can be inherited by a child.
HbAC	Haemoglobin C trait	The C allele also matters in inheritance, including possible HbSC disease when paired with HbS.
HbSS	A common form of sickle cell disease	Affected people need clinical care, not a compatibility score.
HbSC	Sickle haemoglobin C disease	This is a form of sickle cell disease and should not be reduced to a relationship label.
Other patterns	Examples include sickle beta-thalassaemia and other variants	A simple AA/AS/SS menu does not represent every haemoglobin disorder.

The Federal Ministry guideline identifies HbSS, HbSC and sickle beta-thalassaemia among forms of sickle cell disease and distinguishes HbAS trait from disease. That is why a checker covering only familiar labels cannot interpret every possible laboratory report. If a report contains unfamiliar fractions, percentages or a variant name, take the complete report to a qualified professional rather than translating it into the nearest two-letter option.

Screening, confirmation and quality control

A practical testing conversation should cover four questions: what sample was collected, what method was used, what the method can distinguish, and whether confirmation is required. The Nigeria guideline notes that haemoglobin electrophoresis is available in many secondary-care hospitals. Where HPLC and IEF are not accessible, it recommends combining haemoglobin electrophoresis with the outcome of the point-of-care test for confirmatory diagnosis. It also records limitations of electrophoresis and the need for a second-line method in some circumstances.

Do not choose a laboratory only because the result is fast or inexpensive. Ask whether the facility runs known controls, participates in quality assessment, clearly identifies the method and provides a report that a clinician can review. Make sure the name, date of birth or other identifier, collection date and result belong to the tested person. Do not edit, crop or retype a report before sharing it with the professional providing counselling.

Recent blood transfusion and newborn testing can require special interpretation because the haemoglobin detected in a sample may not map neatly to the familiar adult labels. The national guideline has a separate newborn-screening pathway, including sample collection, laboratory processing, reporting and communication of results. Parents should follow the newborn programme or paediatric team's instructions rather than entering an infant result into a general adult compatibility tool.

How inheritance probabilities work

A child receives one haemoglobin allele from each biological parent. A Punnett square lists the possible pairings. When both parents have a confirmed HbAS result, each pregnancy has four equally represented allele pairings in the basic model: HbAA, HbAS, HbAS and HbSS. That produces a 25 percent probability of HbAA, a 50 percent probability of HbAS and a 25 percent probability of HbSS for each pregnancy.

The word each is important. If one child has HbAA, the probabilities for a later pregnancy do not change. Four pregnancies are not guaranteed to produce one child in each quarter of the square. Probability describes possible inheritance in each independent pregnancy, not a promised family sequence.

Confirmed parental results	Possible results in the basic inheritance model	Discussion point
HbAA and HbAS	50% HbAA, 50% HbAS	No HbSS pairing appears in this two-allele model, but the reports still need confirmation.
HbAS and HbAS	25% HbAA, 50% HbAS, 25% HbSS	Discuss the per-pregnancy probabilities with a genetic counsellor.
HbAS and HbAC	25% HbAA, 25% HbAS, 25% HbAC, 25% HbSC	HbSC is a form of sickle cell disease.
HbSS and HbAA	100% HbAS	The person with HbSS needs continuing clinical care regardless of family-planning decisions.

These examples assume that the stated results are correct and that the simplified alleles shown are the relevant ones. They do not cover every haemoglobin variant, reproductive pathway or laboratory uncertainty. The calculator can reproduce the arithmetic, but counselling adds the medical, personal and service context.

What good genetic counselling should provide

The Federal Ministry guideline describes genetic counselling as informative, supportive and non-directive. It says counsellors should give accurate and unbiased information, correct myths, support clients' decisions and avoid telling clients what to do. It also says counselling is important before genetic testing and can help individuals and families understand inheritance, care options and available services.

That standard is especially important because genotype discussions can become stigmatizing or coercive. A result is health information, not a measure of character or relationship value. A person living with sickle cell disease should not be reduced to a risk badge. Couples and families need space to understand confirmed results, inheritance probabilities, care needs and available reproductive options without pressure from an app, relative, employer, school or religious body.

Bring both complete reports to the appointment when possible. Write down questions about the methods, variant names, whether repeat testing is advisable, how results affect future children, and which services are locally available. If the explanation is not clear, ask for plain language or an interpreter. Nigeria's guideline specifically recognizes local-language counselling as important while preserving the essential facts.

Newborn screening is a separate health pathway

Africa CDC reported on May 13, 2026 that African Union Member States had validated a continental plan for sickle cell disease and other inherited blood disorders. The plan covers newborn screening, early diagnosis, treatment, surveillance, financing, research and integrated care. This reflects a broader public-health need: finding affected children early must connect to counselling and continuing care, not stop at the test result.

The WHO Regional Office for Africa's June 2026 PEN-Plus conference programme likewise included screening, testing, essential diagnostics and integrated care for sickle cell disease. These continental and regional commitments do not mean that every country or facility already offers the same service. Ask the maternity facility, paediatric clinic or national programme whether newborn screening is available, when the sample should be taken, how results are confirmed and where positive results are enrolled for care.

Do not wait for an online tool to interpret a newborn result. Follow the clinical programme's communication and referral steps. Nigeria's guideline says newborn results should be communicated with counselling, psychological support, education and referral into comprehensive care for positive cases.

A safer personal testing checklist

1. Find the original report. Do not rely only on a school record, family memory, chat message or compatibility screenshot.
2. Verify identity details. Confirm the tested person's name, relevant identifier, collection date and issuing facility.
3. Identify the method. Ask whether the result came from a screening test, electrophoresis, HPLC, IEF or another validated method.
4. Ask about confirmation. If the screen is positive, the report is unclear or results disagree, ask a qualified professional what second method is appropriate.
5. Share clinical context. Tell the clinician about recent transfusion, age of the person tested, pregnancy or newborn status when relevant.
6. Keep the full report. Preserve fractions, comments and variant names. Do not compress the information into a two-letter label prematurely.
7. Use the calculator for education. Enter only confirmed genotypes and treat percentages as possible inheritance outcomes.
8. Book non-directive counselling. Discuss the result, care needs, family history and available options with a qualified professional.

Common mistakes to avoid

• Treating a screen as a full diagnosis: ask what the method can and cannot distinguish.
• Assuming trait and disease are the same: HbAS trait differs from HbSS or HbSC disease.
• Ignoring haemoglobin C and other variants: a simplified AA/AS/SS conversation can miss relevant patterns.
• Using probabilities as certainty: each pregnancy has its own inheritance event.
• Letting an app make a life decision: a tool can show combinations, but counselling should be informed, supportive and non-directive.
• Sharing sensitive reports widely: disclose health information only to people and services involved in the person's chosen care or counselling.
• Delaying clinical care: anyone with a confirmed disease result or concerning symptoms needs professional assessment, not more online comparisons.

Official sources checked

• Federal Ministry of Health Nigeria, National Guideline for the Control and Management of Sickle Cell Disease, second edition, published in 2025 and checked July 13, 2026. Used for diagnostic methods, confirmation limits, counselling principles and newborn-screening workflow.
• Africa CDC, New Continental Plan to Improve Care for People with Sickle Cell Disease and Other Inherited Blood Disorders, dated May 13, 2026 and checked July 13, 2026.
• WHO Regional Office for Africa, 3rd International Conference on PEN-Plus in Africa, held June 23 to 25, 2026 and checked July 13, 2026. Used for current regional screening, diagnostics and integrated-care context.

Frequently asked questions

Can an online genotype checker diagnose sickle cell disease?

No. It can illustrate inheritance probabilities from genotypes that have already been confirmed. Diagnosis and confirmation require an appropriate laboratory method and clinical interpretation.

Is a positive sickling or solubility test a complete genotype result?

No. The Nigeria guideline treats these as screening approaches with limitations. A positive result can require confirmation with an unrelated second-line method.

What does AS mean on a genotype result?

HbAS usually describes sickle cell trait, with one haemoglobin A allele and one haemoglobin S allele. It is not the same as HbSS disease, but a confirmed result is relevant to inheritance counselling.

Should both partners repeat genotype testing?

If a result is missing, old, unclear, inconsistent or based only on screening, ask a qualified clinician or genetic counsellor whether repeat or confirmatory testing is appropriate. Do not rely on memory or a compatibility screenshot.